Anaphylactoid reactions / anaphylaxis (includes anaphylactic shock)

• (2015): Jares EJ+, J Allergy Clin Immunol Pract 3(5), 78058%

Angioedema (formerly named angioneurotic edema)

• (2017): Dona I+, Allergy 72(9), 1346
• (2014): Dona I+, J Investig Allergol Clin Immunol 24(3), 143

Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))

• (2021): James J+, Curr Drug Saf Oct, Online ahead of print

DRESS syndrome (Drug-induced hypersensitivity syndrome)

• (2017): Matta JM+, An Bras Dermatol 92(1), 30 [REVIEW] (passim)

Exanthems

• (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 539%

Fixed eruption / fixed drug eruption

• (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5316%

Hypersensitivity

• (2014): Dona I+, J Investig Allergol Clin Immunol 24(3), 143 [REVIEW]

Lupus erythematosus (subacute cutaneous lupus erythematosus (SCLE))

• (2012): Dalle Vedove C+, J Dtsch Dermatol Ges 10(12), 889 [REVIEW]

Photosensitivity

• (2017): Lugovic-Mihic L+, Acta Clin Croat 56(2), 277 [REVIEW]
• (2016): Del Vecchio L+, Expert Opin Drug Saf May, Epub ahead of print [REVIEW]
• (2016): Zuba EB+, Acta Dermatovenerol Croat 24(1), 55 [REVIEW]

Rash

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)

• (2022): Shao QH+, Front Pediatr May (e-Collection) (pharmacovigilance)
• (2011): Barvaliya M+, J Postgrad Med 57(2), 11522%
• (2011): Ferrandiz-Pulido C+, Med Clin (Barc) 136(13), 583

Toxic epidermal necrolysis (Lyell's syndrome)

• (2011): Barvaliya M+, J Postgrad Med 57(2), 11522%
• (2011): Ferrandiz-Pulido C+, Med Clin (Barc) 136(13), 583

Urticaria / hives

• (2023): Miniello A+, Endocr Metab Immune Disord Drug Targets Sep, Online ahead of print [REVIEW]
• (2017): Dona I+, Allergy 72(9), 1346
• (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5327%
• (2014): Dona I+, J Investig Allergol Clin Immunol 24(3), 143

Cardiotoxicity

• (2018): Wongrakpanich S+, Aging Dis 9(1), 143 [REVIEW]
• (2017): Varga Z+, Cureus 9(4), e1144 [REVIEW]

Hypertension

• (2017): Varga Z+, Cureus 9(4), e1144 [REVIEW]
• (2015): Richette P+, Expert Opin Drug Saf 14(8), 1259 [REVIEW]

Headache

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]

Vertigo / dizziness

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]

Abdominal pain

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]

Constipation

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]

Diarrhea

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
• (2015): Koffeman AR+, Scand J Prim Health Care 33(3), 1638%

Dyspepsia / functional dyspepsia (indigestion) (see also gastroparesis)

• (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]
• (2015): Koffeman AR+, Scand J Prim Health Care 33(3)_, 16334%

Esophagitis

• (2022): Abdi S+, Gastroenterol Hepatol Bed Bench 15(3), 219-224 [REVIEW]

Gastric obstruction

• (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]

Gastrointestinal adverse reaction

• (2021): McEvoy L+, Front Pharmacol Jun (e-Collection) [REVIEW]

Gastrointestinal bleeding

• (2018): Chi TY+, Medicine (Baltimore) 97(18), e0665
• (2018): Wongrakpanich S+, Aging Dis 9(1), 143 [REVIEW]
• (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]
• (2016): Cardile S+, World J Gastroenterol 22(5), 1877
• (2016): Venerito M+, Pharmaceuticals (Basel) 3(7), 2225 [REVIEW]

Gastrointestinal perforation / perforated colon / gastric perforation

• (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]

Gastrointestinal ulceration

• (2017): Chinese Rheumatism Data Center, Zhonghua Nei Ke Za Zhi (Chinese) 56(1), 81

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)

• (2021): Kong X+, Br J Clin Pharmacol May, Online ahead of print [REVIEW]

Nausea

• (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]

Peptic ulceration (includes duodenal ulcer, esophageal ulcer)

• (2024): Islam H+, Discov Med 36(188), 1789-1799 [REVIEW]
• (2013): Sinha M+, Mediators Inflamm Mar, Epub [REVIEW]

Nephrotoxicity / kidney injury / acute kidney injury (AKI) / drug-induced kidney injury

• (2023): Dobrek L, Life (Basel) 13(2), 325 [REVIEW]
• (2023): Karimzadeh I+, Crit Care 27(1), 435 [REVIEW]
• (2023): Yousif ZK+, Kidney Int Rep 8(11), 2333-2344 (association)
• (2018): Wongrakpanich S+, Aging Dis 9(1), 143 [REVIEW]
• (2016): Vuckovic S+, Curr Med Chem 23(19), 1953
• (2015): Jung JH+, BMC Res Notes 8(1), 793
• (2015): Richette P+, Expert Opin Drug Saf 14(8), 1259 [REVIEW]

Dyspnea / shortness of breath

• (2015): Koffeman AR+, Scand J Prim Health Care 33(3), 1638%

Rhinitis / rhinosinusitis (see also sinusitis)

• (2022): Alromaih S+, Ear Nose Throat J Nov, Online ahead of print [REVIEW]

Adverse effects / adverse reactions

• (2022): Ziesenitz VC+, Paediatr Drugs Sep, Online ahead of print [REVIEW]
• (2016): Gerosa M+, Expert Opin Pharmacother 17(11), 1539 [REVIEW] (in pregnancy)
• (2016): Walters KM+, Immunol Allergy Clin North Am 36(4), 625 [REVIEW]
• (2016): Wong YJ, Evid Based Dent 17(3), 833–44% [REVIEW]
• (2015): Drago F+, Int J Clin Pharm 37(5), 739 (cutaneous)
• (2015): Richette P+, Expert Opin Drug Saf 14(8), 1259 [REVIEW] (gastrointestinal)
• (2015): Tian XY+, Arch Dermatol Res 307(9), 82919% (cutaneous)
• (2014): Carter GT+, Phys Med Rehabil Clin N Am 25(2), 457 [REVIEW]